Vitamin D Dosing: Why Most People Get It Wrong
The mistake isn't the dose — it's dosing to a number instead of a blood level. Here's what the big trials actually showed, the target range that matters, and the two cofactors that decide whether your vitamin D works at all.
Evidence strength
Level 1a
Systematic review of RCTs
Peer-reviewed refs
8
Reading time
9 min
Key Takeaways
- The big trials (VITAL, DO-HEALTH, D-Health) found no cardiovascular, cancer, or mortality benefit from routine supplementation — because they mostly enrolled people who were already replete. The benefit is in correcting genuine deficiency, not topping up the topped-up.
- Dose to a blood level, not a pill count. Target a 25(OH)D of 30–50 ng/mL; for most adults without midday sun that's 2000–4000 IU/day of D3. Retest at 8–12 weeks and adjust.
- Use D3, not D2 — cholecalciferol raises and holds 25(OH)D more effectively than ergocalciferol.
- Magnesium is the cofactor that activates vitamin D; K2 decides where the absorbed calcium goes. Supplementing D alone ignores both.
The problem with vitamin D advice isn't that the doses are wrong. It's that almost everyone doses to a number — 1000 IU because that's what the bottle says, 5000 IU because a podcast said more is better — when the only thing that matters is the level in your blood. Two people on the same dose can sit at wildly different 25(OH)D values, and the dose that fixes a deficiency does nothing for someone already replete.
That single distinction explains why the headlines about vitamin D keep contradicting each other.
Why the Big Trials "Failed"
Three large randomised trials shaped the current, more sober view:
- VITAL randomised 25,871 adults to 2000 IU/day and found no reduction in cardiovascular events or invasive cancer over ~5 years. [1]
- DO-HEALTH gave 2157 older Europeans 2000 IU/day and found no benefit on a composite of blood pressure, infections, falls, fractures, and cognition. [2]
- The D-Health Trial dosed 21,315 adults with 60,000 IU/month and found no reduction in all-cause mortality. [3]
Read quickly, that looks like vitamin D doesn't work. Read carefully, it says something narrower and more useful: supplementing people who are already replete does little. All three trials enrolled largely vitamin-D-sufficient populations. They were testing "does more help the already-fine?" — and the answer was no.
Where the Benefit Actually Lives
When you look at deficient people, or at specific outcomes, signal appears:
- VITAL's fracture analysis and a BMJ meta-analysis of individual participant data found the reduction in acute respiratory infections was concentrated in the most deficient participants — those starting below ~25 nmol/L got the clearest benefit. [5]
- The fracture question is genuinely mixed: a dedicated VITAL analysis found no reduction in fractures in a generally replete population [4] — which again points to the same rule. Correct a deficiency; don't chase benefits by over-topping.
The framing that survives the evidence: vitamin D is a deficiency-correction tool, not a universal enhancer.
Dose to a Level, Not a Pill Count
Here's the practical protocol that follows from all of the above:
- Test your 25(OH)D. This is the circulating form and the only way to know where you stand.
- Target 30–50 ng/mL (75–125 nmol/L). Comfortably out of deficiency, well short of the range where risk creeps back in.
- For most adults without regular midday sun, 2000–4000 IU/day of D3 reaches that range. Bigger bodies need more; deficiency may need a higher short-term correction dose.
- Retest at 8–12 weeks and adjust. Then you can settle into a maintenance dose you've actually verified.
Use D3, Not D2
If you're choosing a supplement: cholecalciferol (D3) beats ergocalciferol (D2). A meta-analysis found D3 raises and sustains 25(OH)D more effectively. [6] D2 is mostly a legacy of prescription high-dose products.
The Two Cofactors Almost Everyone Ignores
Vitamin D doesn't act alone, and this is where most stacks fall short:
- Magnesium is required for every enzymatic step that activates vitamin D. Supplement D while magnesium-deficient and you blunt your own response. [7] Given how common low magnesium intake is, this is not a footnote.
- Vitamin K2 decides where the newly-absorbed calcium goes. D3 increases calcium absorption; K2 routes it into bone and away from arterial walls. The two are covered together in the K2 article.
This is exactly why the Bone & Arterial Longevity protocol treats D3, K2, and magnesium as one system rather than three separate pills.
Is It Safe at These Doses?
Yes. A systematic review of long-term supplementation at 3200–4000 IU/day found no excess adverse events. [8] Toxicity is real but requires sustained intake far higher than this — hypercalcaemia typically appears only above ~10,000 IU/day maintained for months. The exceptions who should get medical guidance first: sarcoidosis, primary hyperparathyroidism, and a history of calcium kidney stones.
The One-Line Version
Test, target 30–50 ng/mL with 2000–4000 IU of D3, retest, and don't take it without magnesium and K2. That's the whole game — and it's a different game from swallowing a fixed number and hoping.
Related Reading
Scientific References
- [1]Manson JE, Cook NR, Lee IM, et al.. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease — New England Journal of Medicine (2019)Oxford 1bPMID 30415629
- [2]Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al.. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial — JAMA (2020)Oxford 1bPMID 33170239
- [3]Neale RE, Baxter C, Romero BD, et al.. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality — Lancet Diabetes & Endocrinology (2022)Oxford 1bPMID 35026158
- [4]LeBoff MS, Chou SH, Ratliff KA, et al.. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults — New England Journal of Medicine (2022)Oxford 1bPMID 35939577
- [5]Martineau AR, Jolliffe DA, Hooper RL, et al.. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data — BMJ (2017)Oxford 1aPMID 28202713
- [6]Tripkovic L, Lambert H, Hart K, et al.. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis — American Journal of Clinical Nutrition (2012)Oxford 1aPMID 22552031
- [7]Uwitonze AM, Razzaque MS.. Role of Magnesium in Vitamin D Activation and Function — Journal of the American Osteopathic Association (2018)Oxford 5PMID 29480918
- [8]Malihi Z, Lawes CMM, Wu Z, et al.. Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials — European Journal of Nutrition (2023)Oxford 1aPMID 36853379
Related protocols
Partner with BiohackingHub
Editorial placements, sponsorships, and product features for evidence-minded brands.